Form 8-K - Current report:
SEC Accession No. 0001104659-25-020599
Filing Date
2025-03-05
Accepted
2025-03-05 07:03:18
Documents
17
Period of Report
2025-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258308d1_8k.htm   iXBRL 8-K 56215
2 EXHIBIT 2.1 tm258308d1_ex2-1.htm EX-2.1 547067
3 EXHIBIT 99.1 tm258308d1_ex99-1.htm EX-99.1 33707
7 GRAPHIC tm258308d1_ex99-1img001.jpg GRAPHIC 15861
8 GRAPHIC tm258308d1_ex99-1img002.jpg GRAPHIC 8554
  Complete submission text file 0001104659-25-020599.txt   987306

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cmrx-20250304.xsd EX-101.SCH 3015
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmrx-20250304_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmrx-20250304_pre.xml EX-101.PRE 22359
19 EXTRACTED XBRL INSTANCE DOCUMENT tm258308d1_8k_htm.xml XML 3680
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

EIN.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35867 | Film No.: 25708793
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)